| Autor: |
Barroso Duarte, Fernando, Gonçalves Lemes, Romélia Pinheiro, de Jesus dos Santos, Talyta Ellen, Cavalcante Barbosa, Maritza, Leitão de Vasconcelos, João Paulo, Rocha-Filho, Francisco Dário, Zalcberg, Ilana, Coutinho, Diego, Feliciano Figueiredo, Monalisa, Barros Carlos, Luciana, Leitão de Vasconcelos, Paulo Roberto, Duarte, Fernando Barroso, Lemes, Romélia Pinheiro Gonçalves, Dos Santos, Talyta Ellen de Jesus, Barbosa, Maritza Cavalcante, de Vasconcelos, João Paulo Leitão, Figueiredo, Monalisa Feliciano, Carlos, Luciana Barros, de Vasconcelos, Paulo Roberto Leitão |
| Předmět: |
|
| Zdroj: |
Journal of Medical Case Reports; 5/21/2017, Vol. 11, p1-4, 4p |
| Abstrakt: |
Background: Myelodysplastic syndromes are heterogeneous disorders. Patients with myelodysplastic syndrome disease often have ineffective hematopoiesis, cytopenias, blood cell dysplasia in one or more cell types, and are at high risk for developing acute myeloid leukemia. In myelodysplastic syndrome, mutations of TP53 gene are usually associated with complex karyotype and confer a worse prognosis. In the present study, two mutations in this gene are presented and discussed with the clinical evolution of the patients.Case Presentation: The first case is a 77-year-old Brazilian woman diagnosed as having multiple lineage dysplasia myelodysplastic syndrome according to World Health Organization 2016 and classified as very low-risk by Revised International Prognostic Scoring. The second case is an 80-year-old Brazilian man also diagnosed as having multiple lineage dysplasia myelodysplastic syndrome and classified as low risk. The mutation described in the first case was already identified in some neoplasias and it is associated with a poor prognosis, but it had never been reported before in myelodysplastic syndrome. The second mutation has never been described.Conclusions: This is a novel report for the scientific community and may be very helpful as we can better understand the disease and the impact of mutations through the follow-up of these patients and others in the future. Both patients are in a good clinical condition, suggesting that these mutations may not alter the clinical course of the disease or may be associated with a good prognosis, but their role in the disease must be investigated more deeply in a larger population. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
